Redmond, WA – According to filings with the U.S. Securities and Exchange Commission, Endogastric Solutions is raising $40,648,791.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Skip Baldino played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Endogastric Solutions

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF) procedures barely invasive solution that addresses a significant unmet clinical need.

To learn more about Endogastric Solutions, visit http://www.endogastricsolutions.com/

Contact:
Skip Baldino, Chief Executive Officer
425-881-9400
skip@endogastricsolutions.com
https://www.linkedin.com/in/skip-baldino-b065186/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved